Evidence map›Paper›PMID 31738948›Full record

ArticleInternational journal of radiation oncology, biology, physics2020

In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.

Zijian Deng, Xiangkun Xu, Tomas Garzon-Muvdi, Yuanxuan Xia, Eileen Kim, Zineb Belcaid, Andrew Luksik, Russell Maxwell, John Choi, Hailun Wang and 5 more

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biomedical optics express · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Quantitative molecular bioluminescence tomography.Journal of biomedical optics · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zijian DengDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Xiangkun XuDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Tomas Garzon-MuvdiDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas.
Yuanxuan XiaDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Eileen KimDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Zineb BelcaidDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Andrew LuksikDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Russell MaxwellDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
John ChoiDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Hailun WangDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jingjing YuSchool of Physics and Information Technology, Shaanxi Normal University, Shanxi, China.
Iulian IordachitaLaboratory for Computational Sensing and Robotics, Johns Hopkins University, Baltimore, Maryland.
Michael LimDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
John W WongDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ken Kang-Hsin WangDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: kwang27@jhmi.edu.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
X-ray/optical tomographic guidance and assessment for pre-clinical radiation ResearchR37CA230341 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WANG, KEN KANG-HSIN · 2019 to 2025
$2.2M
Quantitative bioluminescence tomography for pre-clinical radiotherapy researchR01CA240811 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WANG, KEN KANG-HSIN · 2019 to 2023
$1.3M
A pre-clinical x-ray/optical tomography-guided radiation research platform for pancreatic cancerR21CA223403 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WANG, KEN KANG-HSIN · 2018 to 2019
$386k
NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA240811NCI NIH HHS R21 CA223403NCI NIH HHS R37 CA230341
6 · The paper itself

Abstract

purposeThe cone-beam computed tomography (CBCT)-guided small animal radiation research platform (SARRP) has provided unique opportunities to test radiobiologic hypotheses. However, CBCT is less adept to localize soft tissue targets growing in a low imaging contrast environment. Three-dimensional bioluminescence tomography (BLT) provides strong image contrast and thus offers an attractive solution. We introduced a novel and efficient BLT-guided conformal radiation therapy and demonstrated it in an orthotopic glioblastoma (GBM) model. METHODS AND MATERIALS: A multispectral BLT system was integrated with SARRP for radiation therapy (RT) guidance. GBM growth curve was first established by contrast CBCT/magnetic resonance imaging (MRI) to derive equivalent sphere as approximated gross target volume (aGTV). For BLT, mice were subject to multispectral bioluminescence imaging, followed by SARRP CBCT imaging and optical reconstruction. The CBCT image was acquired to generate anatomic mesh for the reconstruction and RT planning. To ensure high accuracy of the BLT-reconstructed center of mass (CoM) for target localization, we optimized the optical absorption coefficients μ

resultsDeviation between CoMs of BLT reconstruction and contrast CBCT/MRI-imaged GBM is approximately 1 mm. Our derived ETV centered at BLT-reconstructed CoM covers >95% of the tumor volume. Using the second-week GBM as an example, the ETV-based BLT-guided irradiation can cover 95.4% ± 4.7% tumor volume at prescribed dose. The pathologic staining demonstrated the BLT-guided irradiated area overlapped well with the GBM location.

conclusionsThe BLT-guided RT enables 3-dimensional conformal radiation for important orthotopic tumor models, which provides investigators a new preclinical research capability.

Indexed as

Brain NeoplasmsGlioblastomaLuminescent MeasurementsRadiotherapy, ConformalRadiotherapy, Image-GuidedAnimalsCone-Beam Computed TomographyContrast MediaImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance ImagingMiceMice, Inbred C57BLModels, AnimalMultimodal ImagingTumor BurdenContrast Media

Identifiers

PMID31738948
PMCPMC7007925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.